trending Market Intelligence /marketintelligence/en/news-insights/trending/gHywRAKRLjJ48KxS8ZTXmw2 content esgSubNav
In This List

Aldeyra plans $20M 'at the market' offering

Blog

Insight Weekly: Bank boards lag on gender parity; future of office in doubt; US LNG exports leap

Blog

Insight Weekly: Job growth faces hurdles; shale firms sit on cash pile; Africa's lithium future

Blog

Insight Weekly: Loan growth picks up; US-China PE deals fall; France faces winter energy crunch

Blog

Perspectives from China: Chinese M&A in 2022


Aldeyra plans $20M 'at the market' offering

Aldeyra Therapeutics Inc. plans to sell up to $20 million of its common stock from time to time via an "at the market" offering.

Cantor Fitzgerald & Co. will act as agent for the offering, as part of a controlled equity offering sales agreement with Aldeyra Therapeutics.